Literature DB >> 24954623

The diagnosis and treatment of pediatric narcolepsy.

Sona Nevsimalova1.   

Abstract

Narcolepsy in children is a serious disorder marked by a chronic course and lifelong handicap in school performance and choice of employment, by free time activity limitation, and by behavior and personality changes, all of which constitute a major influence on the quality of life. Increased daytime sleepiness may be the only sign at the disease onset, with attacks of sleep becoming longer and lasting up to hours. Also present may be confusional arousals with features of sleep drunkenness. Paradoxically, preschool and young children may show inattentiveness, emotional lability, and hyperactive behavior. Cataplexy may develop after onset of sleepiness and affect mainly muscles of the face. Hypnagogic hallucinations and sleep paralysis are seldom present. Multiple Sleep Latency Test criteria are not available for children younger than 6 years. The haplotype (HLA-DQB1:0602) can be associated with the disorder; however, the best predictor of narcolepsy-cataplexy is hypocretin deficiency. The treatment generally used in adults is regarded as off-label in childhood, which is why the management of pediatric narcolepsy is difficult.

Entities:  

Mesh:

Year:  2014        PMID: 24954623     DOI: 10.1007/s11910-014-0469-1

Source DB:  PubMed          Journal:  Curr Neurol Neurosci Rep        ISSN: 1528-4042            Impact factor:   5.081


  83 in total

1.  Lesson of the week: Narcolepsy mistaken for epilepsy.

Authors:  A Zeman; N Douglas; R Aylward
Journal:  BMJ       Date:  2001-01-27

2.  Reevaluating spells initially identified as cataplexy.

Authors:  Lois E Krahn
Journal:  Sleep Med       Date:  2005-07-05       Impact factor: 3.492

3.  Narcolepsy in children.

Authors:  M J Challamel; M E Mazzola; S Nevsimalova; C Cannard; J Louis; M Revol
Journal:  Sleep       Date:  1994-12       Impact factor: 5.849

4.  Sleep disturbances and hypocretin deficiency in Niemann-Pick disease type C.

Authors:  Jitka Vankova; Iva Stepanova; Robert Jech; Milan Elleder; Lig Ling; Emmanuel Mignot; Seiji Nishino; Sona Nevsimalova
Journal:  Sleep       Date:  2003-06-15       Impact factor: 5.849

5.  Safety profile of modafinil across a range of prescribing indications, including off-label use, in a primary care setting in England: results of a modified prescription-event monitoring study.

Authors:  Miranda Davies; Lynda Wilton; Saad Shakir
Journal:  Drug Saf       Date:  2013-04       Impact factor: 5.606

6.  Pubertal changes in daytime sleepiness.

Authors:  M A Carskadon; K Harvey; P Duke; T F Anders; I F Litt; W C Dement
Journal:  Sleep       Date:  1980       Impact factor: 5.849

7.  A clinical picture of child and adolescent narcolepsy.

Authors:  R E Dahl; J Holttum; L Trubnick
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  1994 Jul-Aug       Impact factor: 8.829

8.  Decreased cerebrospinal fluid hypocretin-1 levels near the onset of narcolepsy in 2 prepubertal children.

Authors:  Hiroaki Kubota; Takashi Kanbayashi; Yuzo Tanabe; Masahiro Ito; Jun-ichi Takanashi; Yoichi Kohno; Tetsuo Shimizu
Journal:  Sleep       Date:  2003-08-01       Impact factor: 5.849

Review 9.  Narcolepsy in childhood.

Authors:  Sona Nevsimalova
Journal:  Sleep Med Rev       Date:  2009-01-18       Impact factor: 11.609

10.  Predictors of hypocretin (orexin) deficiency in narcolepsy without cataplexy.

Authors:  Olivier Andlauer; Hyatt Moore; Seung-Chul Hong; Yves Dauvilliers; Takashi Kanbayashi; Seiji Nishino; Fang Han; Michael H Silber; Tom Rico; Mali Einen; Birgitte R Kornum; Poul Jennum; Stine Knudsen; Sona Nevsimalova; Francesca Poli; Giuseppe Plazzi; Emmanuel Mignot
Journal:  Sleep       Date:  2012-09-01       Impact factor: 5.849

View more
  9 in total

1.  Case 3: Change in personality and daytime sleepiness in a seven-year-old boy.

Authors:  M Sivakumar; Ml Castro Codesal; J E MacLean
Journal:  Paediatr Child Health       Date:  2016-03       Impact factor: 2.253

Review 2.  Cataplexy and sleep disorders in Niemann-Pick type C disease.

Authors:  Sona Nevsimalova; Vera Malinova
Journal:  Curr Neurol Neurosci Rep       Date:  2015-01       Impact factor: 5.081

3.  Long-term safety and maintenance of efficacy of sodium oxybate in the treatment of narcolepsy with cataplexy in pediatric patients.

Authors:  Michel Lecendreux; Giuseppe Plazzi; Yves Dauvilliers; Carol L Rosen; Chad Ruoff; Jed Black; Rupa Parvataneni; Diane Guinta; Y Grace Wang; Emmanuel Mignot
Journal:  J Clin Sleep Med       Date:  2022-09-01       Impact factor: 4.324

4.  Circadian Rest-Activity Rhythm in Pediatric Type 1 Narcolepsy.

Authors:  Marco Filardi; Fabio Pizza; Oliviero Bruni; Vincenzo Natale; Giuseppe Plazzi
Journal:  Sleep       Date:  2016-06-01       Impact factor: 5.849

Review 5.  Treatment of Excessive Daytime Sleepiness in Patients with Narcolepsy.

Authors:  Laura Pérez-Carbonell
Journal:  Curr Treat Options Neurol       Date:  2019-11-12       Impact factor: 3.598

Review 6.  The Medical and Economic Burden of Narcolepsy: Implications for Managed Care.

Authors:  Michael J Thorpy; George Hiller
Journal:  Am Health Drug Benefits       Date:  2017-07

7.  Family functioning among adolescents with narcolepsy.

Authors:  Arpita Parmar; Eluen Ann Yeh; Daphne J Korczak; Shelly K Weiss; Zihang Lu; Allison Zweerink; Alene Toulany; Brian J Murray; Indra Narang
Journal:  Paediatr Child Health       Date:  2019-01-11       Impact factor: 2.253

8.  Methylphenidate and atomoxetine prescribing trends in children in the Western Cape Province of South Africa, 2005-2013.

Authors:  Liezl Joubert; Johanita R Burger; Ilse Truter; Martie S Lubbe; Marike Cockeran
Journal:  Health SA       Date:  2018-07-31

9.  A retrospective analysis of clinical characteristics of childhood narcolepsy.

Authors:  Simranpal Dhanju; Suhail Al-Saleh; Reshma Amin; Shelly K Weiss; Allison Zweerink; Alene Toulany; Brian J Murray; Indra Narang
Journal:  Paediatr Child Health       Date:  2018-03-05       Impact factor: 2.253

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.